Title: EP4 receptor stimulation down-regulates human eosinophil function.
Journal: Cellular and molecular life sciences : CMLS 20111101
Title: The role of the prostaglandin EP4 receptor in the regulation of human outflow facility.
Journal: Investigative ophthalmology & visual science 20110601
Title: Differential reactivity of human mammary artery and saphenous vein to prostaglandin E(2) : implication for cardiovascular grafts.
Journal: British journal of pharmacology 20110601
Title: Effect of PGE2 on DA tone by EP4 modulating Kv channels with different oxygen tension between preterm and term.
Journal: International journal of cardiology 20110217
Title: Differential regulation of the aggressive phenotype of inflammatory breast cancer cells by prostanoid receptors EP3 and EP4.
Journal: Cancer 20100601
Title: Prostaglandin E2 mediates cough via the EP3 receptor: implications for future disease therapy.
Journal: American journal of respiratory and critical care medicine 20091115
Title: EP4 and EP2 receptor subtypes involved in colonic secretion in rat.
Journal: Basic & clinical pharmacology & toxicology 20080901
Title: Activation of prostaglandin EP receptors by lubiprostone in rat and human stomach and colon.
Journal: British journal of pharmacology 20080501
Title: Molecular and pharmacological blockade of the EP4 receptor selectively inhibits both proliferation and invasion of human inflammatory breast cancer cells.
Journal: Journal of experimental therapeutics & oncology 20080101
Title: Characterization of the vasorelaxant mechanisms of the endocannabinoid anandamide in rat aorta.
Journal: British journal of pharmacology 20071101
Title: Selective PPARdelta agonist treatment increases skeletal muscle lipid metabolism without altering mitochondrial energy coupling: an in vivo magnetic resonance spectroscopy study.
Journal: American journal of physiology. Endocrinology and metabolism 20071101
Title: GW627368X ((N-{2-[4-(4,9-diethoxy-1-oxo-1,3-dihydro-2H-benzo[f]isoindol-2-yl)phenyl]acetyl} benzene sulphonamide): a novel, potent and selective prostanoid EP4 receptor antagonist.
Journal: British journal of pharmacology 20060601
Title: Piglet saphenous vein contains multiple relaxatory prostanoid receptors: evidence for EP4, EP2, DP and IP receptor subtypes.
Journal: British journal of pharmacology 20050201
Title: Wilson RJ, et al. GW627368X ((N-{2--(4,9-diethoxy-1-oxo-1,3-dihydro-2H-benzo[fisoindol-2-yl)phenylacetyl} benzene sulphonamide): a novel, potent and selective prostanoid EP4 receptor antagonist. Br J Pharmacol. 2006 Jun;148(3):326-39.
Title: Robertson FM, et al. Molecular and pharmacological blockade of the EP4 receptor selectively inhibits both proliferation and invasion of human inflammatory breast cancer cells. J Exp Ther Oncol. 2008;7(4):299-312.
Title: Parida S, et al. Molecular inhibition of prostaglandin E2 with GW627368X: Therapeutic potential and preclinical safety assessment in mouse sarcoma model. Cancer Biol Ther. 2015;16(6):922-32.
